|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-11-8
|
|
pubmed:abstractText |
It is well known that chemotherapy-induced nausea and vomiting not only produce undesirable physical effects but also reduce patients' willingness to continue chemotherapy. The effect of a 5HT3 receptor antagonist, granisetron, on antiemesis was studied in patients who were receiving cisplatin-based chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0578-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
23-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7553406-Adult,
pubmed-meshheading:7553406-Aged,
pubmed-meshheading:7553406-Antiemetics,
pubmed-meshheading:7553406-Cisplatin,
pubmed-meshheading:7553406-Female,
pubmed-meshheading:7553406-Granisetron,
pubmed-meshheading:7553406-Humans,
pubmed-meshheading:7553406-Injections, Intravenous,
pubmed-meshheading:7553406-Male,
pubmed-meshheading:7553406-Metoclopramide,
pubmed-meshheading:7553406-Middle Aged,
pubmed-meshheading:7553406-Serotonin Antagonists,
pubmed-meshheading:7553406-Vomiting
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis.
|
|
pubmed:affiliation |
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, R.O.C.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
